Akebia Therapeutics Inc. sell StockNews.com
Start price
31.12.24
/
50%
€1.80
Target price
31.12.25
-
Performance (%)
-26.82%
End price
03.01.26
€1.32
Summary
This prediction ended on 03.01.26 with a price of €1.32. The price of Akebia Therapeutics Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -26.82%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | 3.927% | 3.927% | -25.376% |
| iShares Core DAX® | 4.852% | -2.747% | 13.097% |
| iShares Nasdaq 100 | 3.999% | -3.330% | 31.335% |
| iShares Nikkei 225® | 4.221% | -2.912% | 44.472% |
| iShares S&P 500 | 3.324% | -2.954% | 24.360% |
Comments by StockNews_com for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for AKBA provided by MarketBeat
In the thread Trading Akebia Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.28
20.04.24
20.04.24
-
20.04.25
20.04.25
36.64%
21.04.25
21.04.25
